WallStreetZenWallStreetZen

NASDAQ: BNTX
Biontech Se Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

BNTX past earnings growth

How has BNTX's earnings growth performed historically?
Company
-98.13%
Industry
50%
Market
114.07%
BNTX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
BNTX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

BNTX past revenue growth

How has BNTX's revenue growth performed historically?
Company
-77.65%
Industry
172.23%
Market
17.3%
BNTX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BNTX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

BNTX earnings and revenue history

Current Revenue
$3.0B
Current Earnings
$122.8M
Current Profit Margin
4.1%

BNTX Return on Equity

Current Company
0.6%
Current Industry
42.8%
Current Market
28.2%
BNTX's Return on Equity (0.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BNTX announces earnings.

BNTX Return on Assets

Current Company
0.5%
Current Industry
13.1%
BNTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BNTX Return on Capital Employed

Current Company
0.87%
Current Industry
-44.3%
BNTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BNTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BNTX$2.94B$397.96M$121.51M+121.89%-96.92%
ARGX$38.62M-$209.00M-$320.71M+9.84%N/A
ALNY$2.00B-$100.79M-$332.08M+87.56%N/A
GMAB$2.56BN/A$784.32M+42.16%+29.55%
RPRX$2.35B$1.32B$1.13B+5.58%+97.41%
View Top Biotech Stocks

BNTX earnings dates

Next earnings date
May 17, 2024

Biontech Se Earnings & Revenue FAQ

What were BNTX's earnings last quarter?

On Invalid Date, Biontech Se (NASDAQ: BNTX) reported Q1 2024 earnings per share (EPS) of -$1.42, up 163.29% year over year. Total Biontech Se earnings for the quarter were -$342.50 million. In the same quarter last year, Biontech Se's earnings per share (EPS) was $2.25.

If you're new to stock investing, here's how to buy Biontech Se stock.

What was BNTX's earnings growth in the past year?

As of Q2 2024, Biontech Se's earnings has grown -98.13% year over year. This is 148.14 percentage points lower than the US Biotechnology industry earnings growth rate of 50%. Biontech Se's earnings in the past year totalled $121.51 million.

What is BNTX's earnings date?

Biontech Se's earnings date is Invalid Date. Add BNTX to your watchlist to be reminded of BNTX's next earnings announcement.

What was BNTX's revenue last quarter?

On Invalid Date, Biontech Se (NASDAQ: BNTX) reported Q1 2024 revenue of $203.91 million up 85.31% year over year. In the same quarter last year, Biontech Se's revenue was $1.39 billion.

What was BNTX's revenue growth in the past year?

As of Q2 2024, Biontech Se's revenue has grown -77.65% year over year. This is 249.88 percentage points lower than the US Biotechnology industry revenue growth rate of 172.23%. Biontech Se's revenue in the past year totalled $2.94 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.